Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daiko Pharmaceutical is a prominent Japanese consumer healthcare company best known for its flagship gastrointestinal medication, Seirogan, which has been a household staple in Japan for over a century. The company operates primarily through two business segments: Consumer Healthcare, focusing on over-the-counter (OTC) medicines for digestive health, and Infection Control, which produces the Cleverin line of chlorine dioxide-based disinfectant products. Daiko is dedicated to improving global health through traditional herbal-based pharmacology and modern chemical infection prevention technologies. Headquartered in Osaka, the company maintains a significant market presence in East and Southeast Asia. Its research efforts focus on the pharmacological effects of wood creosote and the application of chlorine dioxide for air and surface purification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daiko Pharmaceutical.